Y104L
PDL BIOPHARMA INCData as of 2020 Q3 (09-30) · 13F snapshot
Summary
PDL BIOPHARMA INC (Y104L) is held by 6 tracked hedge-fund managers, a combined reported value of ~$327.20M; the largest are Dan Loeb, Seth Klarman, Renaissance Technologies. Data as of 2020 Q3, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Gurus holding6
Congress trades0
Price—no price
Sectors0
This quarter's moves
Top holderDan LoebNew0
Added0
Trimmed / sold0
Seth KlarmanTrim
Value $49.60M1.5% of portfolio8,000,0002011 Q4
Value $54.0K— of portfolio25,6002016 Q4
Value $50.0K— of portfolio17,2002018 Q4
Value $41.0K— of portfolio11,1002019 Q1
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Seth Klarman | $49.60M | 1.5% | Trim |
| Izzy EnglanderCALL | $54.0K | — | — |
| Ken GriffinPUT | $50.0K | — | — |
| Ken GriffinCALL | $41.0K | — | — |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.